nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—GRIN2B—Alzheimer's disease	0.223	0.658	CbGaD
Haloperidol—GRIN2B—Memantine—Alzheimer's disease	0.177	0.412	CbGbCtD
Haloperidol—SIGMAR1—Donepezil—Alzheimer's disease	0.0962	0.225	CbGbCtD
Haloperidol—HTR2A—Alzheimer's disease	0.0605	0.179	CbGaD
Haloperidol—CYP2D6—Alzheimer's disease	0.0553	0.163	CbGaD
Haloperidol—HTR2A—Donepezil—Alzheimer's disease	0.0378	0.0882	CbGbCtD
Haloperidol—DRD2—Memantine—Alzheimer's disease	0.0302	0.0704	CbGbCtD
Haloperidol—CYP2D6—Rivastigmine—Alzheimer's disease	0.0157	0.0367	CbGbCtD
Haloperidol—CYP2C19—Memantine—Alzheimer's disease	0.0143	0.0334	CbGbCtD
Haloperidol—CYP2C9—Donepezil—Alzheimer's disease	0.0137	0.0321	CbGbCtD
Haloperidol—CYP2D6—Donepezil—Alzheimer's disease	0.0126	0.0293	CbGbCtD
Haloperidol—CYP3A4—Rivastigmine—Alzheimer's disease	0.00999	0.0233	CbGbCtD
Haloperidol—CYP2D6—Galantamine—Alzheimer's disease	0.0081	0.0189	CbGbCtD
Haloperidol—CYP3A4—Donepezil—Alzheimer's disease	0.00799	0.0186	CbGbCtD
Haloperidol—CYP3A4—Galantamine—Alzheimer's disease	0.00515	0.012	CbGbCtD
Haloperidol—GRIN2B—telencephalic ventricle—Alzheimer's disease	0.0036	0.0756	CbGeAlD
Haloperidol—DRD3—telencephalic ventricle—Alzheimer's disease	0.00301	0.0634	CbGeAlD
Haloperidol—HTR2A—choroid plexus—Alzheimer's disease	0.00287	0.0604	CbGeAlD
Haloperidol—DRD1—telencephalic ventricle—Alzheimer's disease	0.00216	0.0454	CbGeAlD
Haloperidol—HTR2A—locus ceruleus—Alzheimer's disease	0.00177	0.0373	CbGeAlD
Haloperidol—HTR1B—telencephalic ventricle—Alzheimer's disease	0.00175	0.0368	CbGeAlD
Haloperidol—HTR1D—telencephalic ventricle—Alzheimer's disease	0.00169	0.0356	CbGeAlD
Haloperidol—HTR2A—cerebellar cortex—Alzheimer's disease	0.00145	0.0304	CbGeAlD
Haloperidol—DRD2—telencephalic ventricle—Alzheimer's disease	0.00127	0.0268	CbGeAlD
Haloperidol—GRIN2B—forebrain—Alzheimer's disease	0.000939	0.0197	CbGeAlD
Haloperidol—HTR1B—blood vessel—Alzheimer's disease	0.000865	0.0182	CbGeAlD
Haloperidol—GRIN2B—telencephalon—Alzheimer's disease	0.000863	0.0182	CbGeAlD
Haloperidol—HTR2A—telencephalic ventricle—Alzheimer's disease	0.000841	0.0177	CbGeAlD
Haloperidol—HTR1D—blood vessel—Alzheimer's disease	0.000838	0.0176	CbGeAlD
Haloperidol—CBR1—forebrain—Alzheimer's disease	0.000696	0.0146	CbGeAlD
Haloperidol—H1F0—embryo—Alzheimer's disease	0.000645	0.0136	CbGeAlD
Haloperidol—CBR1—telencephalon—Alzheimer's disease	0.00064	0.0135	CbGeAlD
Haloperidol—Moclobemide—MAOB—Alzheimer's disease	0.000599	0.203	CrCbGaD
Haloperidol—H1F0—forebrain—Alzheimer's disease	0.000571	0.012	CbGeAlD
Haloperidol—DRD1—forebrain—Alzheimer's disease	0.000563	0.0118	CbGeAlD
Haloperidol—Sertindole—HTR6—Alzheimer's disease	0.000536	0.181	CrCbGaD
Haloperidol—H1F0—telencephalon—Alzheimer's disease	0.000525	0.011	CbGeAlD
Haloperidol—DRD1—telencephalon—Alzheimer's disease	0.000518	0.0109	CbGeAlD
Haloperidol—GRIN2B—nervous system—Alzheimer's disease	0.00051	0.0107	CbGeAlD
Haloperidol—GRIN2B—central nervous system—Alzheimer's disease	0.000491	0.0103	CbGeAlD
Haloperidol—GRIN2B—cerebellum—Alzheimer's disease	0.00048	0.0101	CbGeAlD
Haloperidol—DRD4—brain—Alzheimer's disease	0.000464	0.00977	CbGeAlD
Haloperidol—HTR1B—forebrain—Alzheimer's disease	0.000456	0.0096	CbGeAlD
Haloperidol—HTR1D—forebrain—Alzheimer's disease	0.000442	0.0093	CbGeAlD
Haloperidol—DRD3—nervous system—Alzheimer's disease	0.000427	0.00898	CbGeAlD
Haloperidol—HTR1B—telencephalon—Alzheimer's disease	0.00042	0.00883	CbGeAlD
Haloperidol—HTR2A—blood vessel—Alzheimer's disease	0.000416	0.00875	CbGeAlD
Haloperidol—DRD3—central nervous system—Alzheimer's disease	0.000411	0.00865	CbGeAlD
Haloperidol—HTR2B—forebrain—Alzheimer's disease	0.000411	0.00865	CbGeAlD
Haloperidol—HTR1D—telencephalon—Alzheimer's disease	0.000406	0.00855	CbGeAlD
Haloperidol—GRIN2B—brain—Alzheimer's disease	0.00039	0.00819	CbGeAlD
Haloperidol—SIGMAR1—telencephalon—Alzheimer's disease	0.000379	0.00797	CbGeAlD
Haloperidol—HTR2B—telencephalon—Alzheimer's disease	0.000378	0.00795	CbGeAlD
Haloperidol—CBR1—nervous system—Alzheimer's disease	0.000378	0.00795	CbGeAlD
Haloperidol—CBR1—central nervous system—Alzheimer's disease	0.000364	0.00765	CbGeAlD
Haloperidol—CBR1—cerebellum—Alzheimer's disease	0.000356	0.00748	CbGeAlD
Haloperidol—Face oedema—Donepezil—Alzheimer's disease	0.000344	0.00308	CcSEcCtD
Haloperidol—Libido decreased—Rivastigmine—Alzheimer's disease	0.000341	0.00305	CcSEcCtD
Haloperidol—Urinary retention—Donepezil—Alzheimer's disease	0.000339	0.00303	CcSEcCtD
Haloperidol—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.000335	0.003	CcSEcCtD
Haloperidol—DRD2—forebrain—Alzheimer's disease	0.000333	0.007	CbGeAlD
Haloperidol—Hypoglycaemia—Memantine—Alzheimer's disease	0.000332	0.00297	CcSEcCtD
Haloperidol—Lethargy—Memantine—Alzheimer's disease	0.00033	0.00295	CcSEcCtD
Haloperidol—Liver function test abnormal—Donepezil—Alzheimer's disease	0.000329	0.00294	CcSEcCtD
Haloperidol—KCNH2—forebrain—Alzheimer's disease	0.000328	0.0069	CbGeAlD
Haloperidol—DRD3—brain—Alzheimer's disease	0.000326	0.00687	CbGeAlD
Haloperidol—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000326	0.00291	CcSEcCtD
Haloperidol—Hyponatraemia—Memantine—Alzheimer's disease	0.000325	0.00291	CcSEcCtD
Haloperidol—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.000324	0.0029	CcSEcCtD
Haloperidol—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.000321	0.00287	CcSEcCtD
Haloperidol—Hepatitis—Galantamine—Alzheimer's disease	0.000318	0.00285	CcSEcCtD
Haloperidol—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.000318	0.00284	CcSEcCtD
Haloperidol—Hallucination—Galantamine—Alzheimer's disease	0.000317	0.00283	CcSEcCtD
Haloperidol—Psychotic disorder—Memantine—Alzheimer's disease	0.000316	0.00283	CcSEcCtD
Haloperidol—Urinary tract disorder—Galantamine—Alzheimer's disease	0.000314	0.00281	CcSEcCtD
Haloperidol—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.000314	0.00281	CcSEcCtD
Haloperidol—Connective tissue disorder—Galantamine—Alzheimer's disease	0.000313	0.0028	CcSEcCtD
Haloperidol—Urethral disorder—Galantamine—Alzheimer's disease	0.000312	0.00279	CcSEcCtD
Haloperidol—H1F0—nervous system—Alzheimer's disease	0.00031	0.00651	CbGeAlD
Haloperidol—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.000309	0.00277	CcSEcCtD
Haloperidol—Dysphagia—Donepezil—Alzheimer's disease	0.000308	0.00276	CcSEcCtD
Haloperidol—Cardiac arrest—Memantine—Alzheimer's disease	0.000308	0.00275	CcSEcCtD
Haloperidol—Urinary retention—Memantine—Alzheimer's disease	0.000308	0.00275	CcSEcCtD
Haloperidol—Visual impairment—Galantamine—Alzheimer's disease	0.000307	0.00274	CcSEcCtD
Haloperidol—DRD2—telencephalon—Alzheimer's disease	0.000306	0.00644	CbGeAlD
Haloperidol—DRD1—nervous system—Alzheimer's disease	0.000306	0.00643	CbGeAlD
Haloperidol—Face oedema—Rivastigmine—Alzheimer's disease	0.000306	0.00273	CcSEcCtD
Haloperidol—Loperamide—CALM1—Alzheimer's disease	0.000303	0.102	CrCbGaD
Haloperidol—KCNH2—telencephalon—Alzheimer's disease	0.000302	0.00634	CbGeAlD
Haloperidol—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.000301	0.00269	CcSEcCtD
Haloperidol—Urinary retention—Rivastigmine—Alzheimer's disease	0.000301	0.00269	CcSEcCtD
Haloperidol—Sweating increased—Donepezil—Alzheimer's disease	0.0003	0.00268	CcSEcCtD
Haloperidol—Liver function test abnormal—Memantine—Alzheimer's disease	0.000299	0.00267	CcSEcCtD
Haloperidol—H1F0—central nervous system—Alzheimer's disease	0.000298	0.00627	CbGeAlD
Haloperidol—Eye disorder—Galantamine—Alzheimer's disease	0.000297	0.00266	CcSEcCtD
Haloperidol—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000296	0.00264	CcSEcCtD
Haloperidol—Cardiac disorder—Galantamine—Alzheimer's disease	0.000295	0.00264	CcSEcCtD
Haloperidol—DRD1—central nervous system—Alzheimer's disease	0.000294	0.00619	CbGeAlD
Haloperidol—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.000292	0.00261	CcSEcCtD
Haloperidol—H1F0—cerebellum—Alzheimer's disease	0.000291	0.00613	CbGeAlD
Haloperidol—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000289	0.00259	CcSEcCtD
Haloperidol—CBR1—brain—Alzheimer's disease	0.000289	0.00608	CbGeAlD
Haloperidol—Angiopathy—Galantamine—Alzheimer's disease	0.000289	0.00258	CcSEcCtD
Haloperidol—Immune system disorder—Galantamine—Alzheimer's disease	0.000287	0.00257	CcSEcCtD
Haloperidol—Breast disorder—Rivastigmine—Alzheimer's disease	0.000286	0.00256	CcSEcCtD
Haloperidol—Weight increased—Donepezil—Alzheimer's disease	0.00028	0.00251	CcSEcCtD
Haloperidol—Dysphagia—Memantine—Alzheimer's disease	0.00028	0.0025	CcSEcCtD
Haloperidol—Mental disorder—Galantamine—Alzheimer's disease	0.000279	0.00249	CcSEcCtD
Haloperidol—Weight decreased—Donepezil—Alzheimer's disease	0.000279	0.00249	CcSEcCtD
Haloperidol—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000278	0.00249	CcSEcCtD
Haloperidol—Malnutrition—Galantamine—Alzheimer's disease	0.000277	0.00248	CcSEcCtD
Haloperidol—Bronchospasm—Memantine—Alzheimer's disease	0.000275	0.00246	CcSEcCtD
Haloperidol—Depression—Donepezil—Alzheimer's disease	0.000274	0.00245	CcSEcCtD
Haloperidol—Dysphagia—Rivastigmine—Alzheimer's disease	0.000274	0.00245	CcSEcCtD
Haloperidol—ABCB1—blood vessel—Alzheimer's disease	0.000273	0.00574	CbGeAlD
Haloperidol—Sweating increased—Memantine—Alzheimer's disease	0.000273	0.00244	CcSEcCtD
Haloperidol—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000269	0.00241	CcSEcCtD
Haloperidol—Jaundice—Donepezil—Alzheimer's disease	0.000268	0.00239	CcSEcCtD
Haloperidol—Sweating increased—Rivastigmine—Alzheimer's disease	0.000267	0.00238	CcSEcCtD
Haloperidol—Muscle spasms—Galantamine—Alzheimer's disease	0.000266	0.00238	CcSEcCtD
Haloperidol—Pancytopenia—Memantine—Alzheimer's disease	0.000266	0.00238	CcSEcCtD
Haloperidol—HRH1—forebrain—Alzheimer's disease	0.000263	0.00553	CbGeAlD
Haloperidol—Neutropenia—Memantine—Alzheimer's disease	0.000262	0.00234	CcSEcCtD
Haloperidol—Vision blurred—Galantamine—Alzheimer's disease	0.000261	0.00233	CcSEcCtD
Haloperidol—Tremor—Galantamine—Alzheimer's disease	0.00026	0.00232	CcSEcCtD
Haloperidol—Erectile dysfunction—Memantine—Alzheimer's disease	0.000258	0.0023	CcSEcCtD
Haloperidol—Anaemia—Galantamine—Alzheimer's disease	0.000256	0.00229	CcSEcCtD
Haloperidol—Weight increased—Memantine—Alzheimer's disease	0.000255	0.00228	CcSEcCtD
Haloperidol—Agitation—Galantamine—Alzheimer's disease	0.000255	0.00228	CcSEcCtD
Haloperidol—Weight decreased—Memantine—Alzheimer's disease	0.000253	0.00226	CcSEcCtD
Haloperidol—Hyperglycaemia—Memantine—Alzheimer's disease	0.000252	0.00226	CcSEcCtD
Haloperidol—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000252	0.00225	CcSEcCtD
Haloperidol—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.00025	0.00223	CcSEcCtD
Haloperidol—Weight increased—Rivastigmine—Alzheimer's disease	0.000249	0.00223	CcSEcCtD
Haloperidol—Vertigo—Galantamine—Alzheimer's disease	0.000249	0.00223	CcSEcCtD
Haloperidol—Depression—Memantine—Alzheimer's disease	0.000249	0.00222	CcSEcCtD
Haloperidol—HTR2A—embryo—Alzheimer's disease	0.000248	0.00522	CbGeAlD
Haloperidol—HTR1B—nervous system—Alzheimer's disease	0.000248	0.00521	CbGeAlD
Haloperidol—Weight decreased—Rivastigmine—Alzheimer's disease	0.000248	0.00221	CcSEcCtD
Haloperidol—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000247	0.00221	CcSEcCtD
Haloperidol—Hepatitis—Donepezil—Alzheimer's disease	0.000247	0.00221	CcSEcCtD
Haloperidol—Hallucination—Donepezil—Alzheimer's disease	0.000245	0.00219	CcSEcCtD
Haloperidol—Droperidol—HTR2A—Alzheimer's disease	0.000245	0.0828	CrCbGaD
Haloperidol—Drowsiness—Rivastigmine—Alzheimer's disease	0.000244	0.00218	CcSEcCtD
Haloperidol—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000244	0.00218	CcSEcCtD
Haloperidol—Depression—Rivastigmine—Alzheimer's disease	0.000243	0.00218	CcSEcCtD
Haloperidol—Urethral disorder—Donepezil—Alzheimer's disease	0.000242	0.00216	CcSEcCtD
Haloperidol—HRH1—telencephalon—Alzheimer's disease	0.000242	0.00508	CbGeAlD
Haloperidol—Convulsion—Galantamine—Alzheimer's disease	0.00024	0.00215	CcSEcCtD
Haloperidol—HTR1D—nervous system—Alzheimer's disease	0.00024	0.00505	CbGeAlD
Haloperidol—Hypertension—Galantamine—Alzheimer's disease	0.000239	0.00214	CcSEcCtD
Haloperidol—HTR1B—central nervous system—Alzheimer's disease	0.000239	0.00502	CbGeAlD
Haloperidol—Visual impairment—Donepezil—Alzheimer's disease	0.000238	0.00213	CcSEcCtD
Haloperidol—H1F0—brain—Alzheimer's disease	0.000237	0.00498	CbGeAlD
Haloperidol—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000236	0.00211	CcSEcCtD
Haloperidol—Anxiety—Galantamine—Alzheimer's disease	0.000235	0.0021	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000234	0.00209	CcSEcCtD
Haloperidol—DRD1—brain—Alzheimer's disease	0.000234	0.00492	CbGeAlD
Haloperidol—Agranulocytosis—Memantine—Alzheimer's disease	0.000233	0.00208	CcSEcCtD
Haloperidol—HTR1D—central nervous system—Alzheimer's disease	0.000231	0.00486	CbGeAlD
Haloperidol—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000231	0.00206	CcSEcCtD
Haloperidol—Dry mouth—Galantamine—Alzheimer's disease	0.000231	0.00206	CcSEcCtD
Haloperidol—Confusional state—Galantamine—Alzheimer's disease	0.000228	0.00204	CcSEcCtD
Haloperidol—Hepatitis—Memantine—Alzheimer's disease	0.000224	0.002	CcSEcCtD
Haloperidol—HTR2B—nervous system—Alzheimer's disease	0.000223	0.00469	CbGeAlD
Haloperidol—Hallucination—Memantine—Alzheimer's disease	0.000223	0.00199	CcSEcCtD
Haloperidol—Nervous system disorder—Galantamine—Alzheimer's disease	0.000222	0.00198	CcSEcCtD
Haloperidol—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000221	0.00198	CcSEcCtD
Haloperidol—Urinary tract disorder—Memantine—Alzheimer's disease	0.000221	0.00198	CcSEcCtD
Haloperidol—Tachycardia—Galantamine—Alzheimer's disease	0.000221	0.00197	CcSEcCtD
Haloperidol—Connective tissue disorder—Memantine—Alzheimer's disease	0.00022	0.00197	CcSEcCtD
Haloperidol—Skin disorder—Galantamine—Alzheimer's disease	0.00022	0.00196	CcSEcCtD
Haloperidol—HTR2A—forebrain—Alzheimer's disease	0.00022	0.00462	CbGeAlD
Haloperidol—Urethral disorder—Memantine—Alzheimer's disease	0.00022	0.00196	CcSEcCtD
Haloperidol—Hepatitis—Rivastigmine—Alzheimer's disease	0.000219	0.00196	CcSEcCtD
Haloperidol—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000219	0.00195	CcSEcCtD
Haloperidol—Hallucination—Rivastigmine—Alzheimer's disease	0.000218	0.00195	CcSEcCtD
Haloperidol—Alopecia—Donepezil—Alzheimer's disease	0.000218	0.00195	CcSEcCtD
Haloperidol—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000216	0.00193	CcSEcCtD
Haloperidol—Mental disorder—Donepezil—Alzheimer's disease	0.000216	0.00193	CcSEcCtD
Haloperidol—Visual impairment—Memantine—Alzheimer's disease	0.000216	0.00193	CcSEcCtD
Haloperidol—Anorexia—Galantamine—Alzheimer's disease	0.000216	0.00193	CcSEcCtD
Haloperidol—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000215	0.00192	CcSEcCtD
Haloperidol—HTR2B—central nervous system—Alzheimer's disease	0.000215	0.00452	CbGeAlD
Haloperidol—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000215	0.00192	CcSEcCtD
Haloperidol—Malnutrition—Donepezil—Alzheimer's disease	0.000215	0.00192	CcSEcCtD
Haloperidol—Hypotension—Galantamine—Alzheimer's disease	0.000211	0.00189	CcSEcCtD
Haloperidol—Visual impairment—Rivastigmine—Alzheimer's disease	0.000211	0.00189	CcSEcCtD
Haloperidol—SIGMAR1—cerebellum—Alzheimer's disease	0.00021	0.00443	CbGeAlD
Haloperidol—Eye disorder—Memantine—Alzheimer's disease	0.000209	0.00187	CcSEcCtD
Haloperidol—Cardiac disorder—Memantine—Alzheimer's disease	0.000208	0.00186	CcSEcCtD
Haloperidol—Muscle spasms—Donepezil—Alzheimer's disease	0.000206	0.00185	CcSEcCtD
Haloperidol—Sertindole—SLC6A4—Alzheimer's disease	0.000205	0.0695	CrCbGaD
Haloperidol—Mazindol—SLC6A4—Alzheimer's disease	0.000205	0.0695	CrCbGaD
Haloperidol—Eye disorder—Rivastigmine—Alzheimer's disease	0.000205	0.00183	CcSEcCtD
Haloperidol—Insomnia—Galantamine—Alzheimer's disease	0.000204	0.00183	CcSEcCtD
Haloperidol—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000203	0.00182	CcSEcCtD
Haloperidol—Angiopathy—Memantine—Alzheimer's disease	0.000203	0.00182	CcSEcCtD
Haloperidol—Vision blurred—Donepezil—Alzheimer's disease	0.000202	0.00181	CcSEcCtD
Haloperidol—Immune system disorder—Memantine—Alzheimer's disease	0.000202	0.00181	CcSEcCtD
Haloperidol—HTR2A—telencephalon—Alzheimer's disease	0.000202	0.00425	CbGeAlD
Haloperidol—Mediastinal disorder—Memantine—Alzheimer's disease	0.000202	0.0018	CcSEcCtD
Haloperidol—Tremor—Donepezil—Alzheimer's disease	0.000201	0.0018	CcSEcCtD
Haloperidol—Somnolence—Galantamine—Alzheimer's disease	0.000201	0.0018	CcSEcCtD
Haloperidol—CYP2D6—forebrain—Alzheimer's disease	0.0002	0.00421	CbGeAlD
Haloperidol—Dyspepsia—Galantamine—Alzheimer's disease	0.000199	0.00178	CcSEcCtD
Haloperidol—Angiopathy—Rivastigmine—Alzheimer's disease	0.000199	0.00178	CcSEcCtD
Haloperidol—Anaemia—Donepezil—Alzheimer's disease	0.000198	0.00177	CcSEcCtD
Haloperidol—Alopecia—Memantine—Alzheimer's disease	0.000198	0.00177	CcSEcCtD
Haloperidol—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000197	0.00177	CcSEcCtD
Haloperidol—Agitation—Donepezil—Alzheimer's disease	0.000197	0.00176	CcSEcCtD
Haloperidol—Decreased appetite—Galantamine—Alzheimer's disease	0.000197	0.00176	CcSEcCtD
Haloperidol—Mental disorder—Memantine—Alzheimer's disease	0.000196	0.00175	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000195	0.00175	CcSEcCtD
Haloperidol—Malnutrition—Memantine—Alzheimer's disease	0.000195	0.00174	CcSEcCtD
Haloperidol—Alopecia—Rivastigmine—Alzheimer's disease	0.000194	0.00173	CcSEcCtD
Haloperidol—Constipation—Galantamine—Alzheimer's disease	0.000193	0.00173	CcSEcCtD
Haloperidol—Vertigo—Donepezil—Alzheimer's disease	0.000193	0.00172	CcSEcCtD
Haloperidol—Mental disorder—Rivastigmine—Alzheimer's disease	0.000192	0.00172	CcSEcCtD
Haloperidol—Malnutrition—Rivastigmine—Alzheimer's disease	0.000191	0.00171	CcSEcCtD
Haloperidol—Moclobemide—CYP2D6—Alzheimer's disease	0.00019	0.0644	CrCbGaD
Haloperidol—HTR1B—brain—Alzheimer's disease	0.000189	0.00398	CbGeAlD
Haloperidol—Feeling abnormal—Galantamine—Alzheimer's disease	0.000186	0.00167	CcSEcCtD
Haloperidol—Convulsion—Donepezil—Alzheimer's disease	0.000186	0.00166	CcSEcCtD
Haloperidol—Hypertension—Donepezil—Alzheimer's disease	0.000185	0.00166	CcSEcCtD
Haloperidol—CYP2D6—telencephalon—Alzheimer's disease	0.000184	0.00387	CbGeAlD
Haloperidol—Vision blurred—Memantine—Alzheimer's disease	0.000184	0.00164	CcSEcCtD
Haloperidol—HTR1D—brain—Alzheimer's disease	0.000183	0.00386	CbGeAlD
Haloperidol—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000183	0.00164	CcSEcCtD
Haloperidol—Tremor—Memantine—Alzheimer's disease	0.000183	0.00163	CcSEcCtD
Haloperidol—Anxiety—Donepezil—Alzheimer's disease	0.000182	0.00163	CcSEcCtD
Haloperidol—DRD2—nervous system—Alzheimer's disease	0.000181	0.0038	CbGeAlD
Haloperidol—Anaemia—Memantine—Alzheimer's disease	0.00018	0.00161	CcSEcCtD
Haloperidol—Vision blurred—Rivastigmine—Alzheimer's disease	0.00018	0.00161	CcSEcCtD
Haloperidol—Agitation—Memantine—Alzheimer's disease	0.000179	0.0016	CcSEcCtD
Haloperidol—Dry mouth—Donepezil—Alzheimer's disease	0.000179	0.0016	CcSEcCtD
Haloperidol—Body temperature increased—Galantamine—Alzheimer's disease	0.000179	0.0016	CcSEcCtD
Haloperidol—Tremor—Rivastigmine—Alzheimer's disease	0.000179	0.0016	CcSEcCtD
Haloperidol—KCNH2—nervous system—Alzheimer's disease	0.000178	0.00374	CbGeAlD
Haloperidol—Confusional state—Donepezil—Alzheimer's disease	0.000177	0.00158	CcSEcCtD
Haloperidol—Anaemia—Rivastigmine—Alzheimer's disease	0.000176	0.00158	CcSEcCtD
Haloperidol—Agitation—Rivastigmine—Alzheimer's disease	0.000175	0.00157	CcSEcCtD
Haloperidol—Oedema—Donepezil—Alzheimer's disease	0.000175	0.00157	CcSEcCtD
Haloperidol—Vertigo—Memantine—Alzheimer's disease	0.000175	0.00157	CcSEcCtD
Haloperidol—Leukopenia—Memantine—Alzheimer's disease	0.000174	0.00156	CcSEcCtD
Haloperidol—DRD2—central nervous system—Alzheimer's disease	0.000174	0.00366	CbGeAlD
Haloperidol—Nervous system disorder—Donepezil—Alzheimer's disease	0.000172	0.00154	CcSEcCtD
Haloperidol—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000172	0.00153	CcSEcCtD
Haloperidol—KCNH2—central nervous system—Alzheimer's disease	0.000171	0.00361	CbGeAlD
Haloperidol—Vertigo—Rivastigmine—Alzheimer's disease	0.000171	0.00153	CcSEcCtD
Haloperidol—SIGMAR1—brain—Alzheimer's disease	0.000171	0.0036	CbGeAlD
Haloperidol—HTR2B—brain—Alzheimer's disease	0.000171	0.00359	CbGeAlD
Haloperidol—DRD2—cerebellum—Alzheimer's disease	0.00017	0.00358	CbGeAlD
Haloperidol—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000169	0.00151	CcSEcCtD
Haloperidol—Convulsion—Memantine—Alzheimer's disease	0.000169	0.00151	CcSEcCtD
Haloperidol—Hypertension—Memantine—Alzheimer's disease	0.000168	0.0015	CcSEcCtD
Haloperidol—KCNH2—cerebellum—Alzheimer's disease	0.000168	0.00352	CbGeAlD
Haloperidol—Fluspirilene—SLC6A4—Alzheimer's disease	0.000167	0.0566	CrCbGaD
Haloperidol—Anorexia—Donepezil—Alzheimer's disease	0.000167	0.00149	CcSEcCtD
Haloperidol—Hypersensitivity—Galantamine—Alzheimer's disease	0.000167	0.00149	CcSEcCtD
Haloperidol—Anxiety—Memantine—Alzheimer's disease	0.000165	0.00148	CcSEcCtD
Haloperidol—Convulsion—Rivastigmine—Alzheimer's disease	0.000165	0.00148	CcSEcCtD
Haloperidol—Hypertension—Rivastigmine—Alzheimer's disease	0.000165	0.00147	CcSEcCtD
Haloperidol—Hypotension—Donepezil—Alzheimer's disease	0.000164	0.00146	CcSEcCtD
Haloperidol—ABCB1—embryo—Alzheimer's disease	0.000163	0.00342	CbGeAlD
Haloperidol—Dry mouth—Memantine—Alzheimer's disease	0.000162	0.00145	CcSEcCtD
Haloperidol—Anxiety—Rivastigmine—Alzheimer's disease	0.000162	0.00145	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000161	0.00144	CcSEcCtD
Haloperidol—Confusional state—Memantine—Alzheimer's disease	0.00016	0.00143	CcSEcCtD
Haloperidol—Oedema—Memantine—Alzheimer's disease	0.000159	0.00142	CcSEcCtD
Haloperidol—Dry mouth—Rivastigmine—Alzheimer's disease	0.000159	0.00142	CcSEcCtD
Haloperidol—Insomnia—Donepezil—Alzheimer's disease	0.000158	0.00142	CcSEcCtD
Haloperidol—Sertindole—HTR2A—Alzheimer's disease	0.000158	0.0534	CrCbGaD
Haloperidol—Confusional state—Rivastigmine—Alzheimer's disease	0.000157	0.0014	CcSEcCtD
Haloperidol—Dyspnoea—Donepezil—Alzheimer's disease	0.000156	0.0014	CcSEcCtD
Haloperidol—Nervous system disorder—Memantine—Alzheimer's disease	0.000156	0.0014	CcSEcCtD
Haloperidol—Somnolence—Donepezil—Alzheimer's disease	0.000156	0.00139	CcSEcCtD
Haloperidol—Thrombocytopenia—Memantine—Alzheimer's disease	0.000156	0.00139	CcSEcCtD
Haloperidol—Oedema—Rivastigmine—Alzheimer's disease	0.000156	0.00139	CcSEcCtD
Haloperidol—Tachycardia—Memantine—Alzheimer's disease	0.000155	0.00139	CcSEcCtD
Haloperidol—Diarrhoea—Galantamine—Alzheimer's disease	0.000155	0.00138	CcSEcCtD
Haloperidol—Skin disorder—Memantine—Alzheimer's disease	0.000155	0.00138	CcSEcCtD
Haloperidol—Dyspepsia—Donepezil—Alzheimer's disease	0.000154	0.00138	CcSEcCtD
Haloperidol—Hyperhidrosis—Memantine—Alzheimer's disease	0.000154	0.00138	CcSEcCtD
Haloperidol—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000153	0.00136	CcSEcCtD
Haloperidol—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000152	0.00136	CcSEcCtD
Haloperidol—Decreased appetite—Donepezil—Alzheimer's disease	0.000152	0.00136	CcSEcCtD
Haloperidol—Tachycardia—Rivastigmine—Alzheimer's disease	0.000152	0.00136	CcSEcCtD
Haloperidol—Anorexia—Memantine—Alzheimer's disease	0.000152	0.00136	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000151	0.00135	CcSEcCtD
Haloperidol—Skin disorder—Rivastigmine—Alzheimer's disease	0.000151	0.00135	CcSEcCtD
Haloperidol—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00015	0.00135	CcSEcCtD
Haloperidol—CYP1A1—nervous system—Alzheimer's disease	0.00015	0.00316	CbGeAlD
Haloperidol—Constipation—Donepezil—Alzheimer's disease	0.00015	0.00134	CcSEcCtD
Haloperidol—Dizziness—Galantamine—Alzheimer's disease	0.00015	0.00134	CcSEcCtD
Haloperidol—Hypotension—Memantine—Alzheimer's disease	0.000149	0.00133	CcSEcCtD
Haloperidol—Anorexia—Rivastigmine—Alzheimer's disease	0.000148	0.00133	CcSEcCtD
Haloperidol—Hypotension—Rivastigmine—Alzheimer's disease	0.000145	0.0013	CcSEcCtD
Haloperidol—CYP1A1—central nervous system—Alzheimer's disease	0.000145	0.00304	CbGeAlD
Haloperidol—Feeling abnormal—Donepezil—Alzheimer's disease	0.000144	0.00129	CcSEcCtD
Haloperidol—Sertindole—CYP2D6—Alzheimer's disease	0.000144	0.0488	CrCbGaD
Haloperidol—Insomnia—Memantine—Alzheimer's disease	0.000144	0.00129	CcSEcCtD
Haloperidol—ABCB1—forebrain—Alzheimer's disease	0.000144	0.00303	CbGeAlD
Haloperidol—Vomiting—Galantamine—Alzheimer's disease	0.000144	0.00129	CcSEcCtD
Haloperidol—HRH1—nervous system—Alzheimer's disease	0.000143	0.003	CbGeAlD
Haloperidol—Rash—Galantamine—Alzheimer's disease	0.000143	0.00127	CcSEcCtD
Haloperidol—Dermatitis—Galantamine—Alzheimer's disease	0.000142	0.00127	CcSEcCtD
Haloperidol—Dyspnoea—Memantine—Alzheimer's disease	0.000142	0.00127	CcSEcCtD
Haloperidol—Headache—Galantamine—Alzheimer's disease	0.000142	0.00127	CcSEcCtD
Haloperidol—Somnolence—Memantine—Alzheimer's disease	0.000141	0.00126	CcSEcCtD
Haloperidol—Insomnia—Rivastigmine—Alzheimer's disease	0.000141	0.00126	CcSEcCtD
Haloperidol—Dyspepsia—Memantine—Alzheimer's disease	0.00014	0.00125	CcSEcCtD
Haloperidol—Urticaria—Donepezil—Alzheimer's disease	0.000139	0.00124	CcSEcCtD
Haloperidol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000139	0.00124	CcSEcCtD
Haloperidol—Body temperature increased—Donepezil—Alzheimer's disease	0.000139	0.00124	CcSEcCtD
Haloperidol—Somnolence—Rivastigmine—Alzheimer's disease	0.000138	0.00124	CcSEcCtD
Haloperidol—Decreased appetite—Memantine—Alzheimer's disease	0.000138	0.00124	CcSEcCtD
Haloperidol—DRD2—brain—Alzheimer's disease	0.000138	0.0029	CbGeAlD
Haloperidol—HRH1—central nervous system—Alzheimer's disease	0.000137	0.00289	CbGeAlD
Haloperidol—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000137	0.00123	CcSEcCtD
Haloperidol—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000137	0.00123	CcSEcCtD
Haloperidol—KCNH2—brain—Alzheimer's disease	0.000136	0.00286	CbGeAlD
Haloperidol—Constipation—Memantine—Alzheimer's disease	0.000136	0.00122	CcSEcCtD
Haloperidol—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000135	0.00121	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000134	0.0012	CcSEcCtD
Haloperidol—Nausea—Galantamine—Alzheimer's disease	0.000134	0.0012	CcSEcCtD
Haloperidol—Constipation—Rivastigmine—Alzheimer's disease	0.000133	0.00119	CcSEcCtD
Haloperidol—ABCB1—telencephalon—Alzheimer's disease	0.000132	0.00278	CbGeAlD
Haloperidol—Feeling abnormal—Memantine—Alzheimer's disease	0.000131	0.00117	CcSEcCtD
Haloperidol—Hypersensitivity—Donepezil—Alzheimer's disease	0.000129	0.00115	CcSEcCtD
Haloperidol—Fluspirilene—HTR2A—Alzheimer's disease	0.000129	0.0435	CrCbGaD
Haloperidol—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000128	0.00115	CcSEcCtD
Haloperidol—Urticaria—Memantine—Alzheimer's disease	0.000126	0.00113	CcSEcCtD
Haloperidol—Body temperature increased—Memantine—Alzheimer's disease	0.000126	0.00112	CcSEcCtD
Haloperidol—Pruritus—Donepezil—Alzheimer's disease	0.000124	0.00111	CcSEcCtD
Haloperidol—Urticaria—Rivastigmine—Alzheimer's disease	0.000124	0.00111	CcSEcCtD
Haloperidol—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000123	0.0011	CcSEcCtD
Haloperidol—Diarrhoea—Donepezil—Alzheimer's disease	0.00012	0.00107	CcSEcCtD
Haloperidol—HTR2A—nervous system—Alzheimer's disease	0.000119	0.00251	CbGeAlD
Haloperidol—Hypersensitivity—Memantine—Alzheimer's disease	0.000117	0.00105	CcSEcCtD
Haloperidol—Dizziness—Donepezil—Alzheimer's disease	0.000116	0.00104	CcSEcCtD
Haloperidol—CYP1A1—brain—Alzheimer's disease	0.000115	0.00242	CbGeAlD
Haloperidol—HTR2A—central nervous system—Alzheimer's disease	0.000115	0.00241	CbGeAlD
Haloperidol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000115	0.00103	CcSEcCtD
Haloperidol—Pruritus—Memantine—Alzheimer's disease	0.000113	0.00101	CcSEcCtD
Haloperidol—HTR2A—cerebellum—Alzheimer's disease	0.000112	0.00236	CbGeAlD
Haloperidol—Vomiting—Donepezil—Alzheimer's disease	0.000111	0.000996	CcSEcCtD
Haloperidol—Rash—Donepezil—Alzheimer's disease	0.00011	0.000988	CcSEcCtD
Haloperidol—Dermatitis—Donepezil—Alzheimer's disease	0.00011	0.000987	CcSEcCtD
Haloperidol—CYP3A4—nervous system—Alzheimer's disease	0.00011	0.00232	CbGeAlD
Haloperidol—Pruritus—Rivastigmine—Alzheimer's disease	0.00011	0.000985	CcSEcCtD
Haloperidol—Headache—Donepezil—Alzheimer's disease	0.00011	0.000982	CcSEcCtD
Haloperidol—HRH1—brain—Alzheimer's disease	0.000109	0.00229	CbGeAlD
Haloperidol—Diarrhoea—Memantine—Alzheimer's disease	0.000109	0.000973	CcSEcCtD
Haloperidol—CYP2D6—nervous system—Alzheimer's disease	0.000109	0.00228	CbGeAlD
Haloperidol—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000106	0.000952	CcSEcCtD
Haloperidol—CYP3A4—central nervous system—Alzheimer's disease	0.000106	0.00223	CbGeAlD
Haloperidol—Dizziness—Memantine—Alzheimer's disease	0.000105	0.000941	CcSEcCtD
Haloperidol—CYP2D6—central nervous system—Alzheimer's disease	0.000105	0.0022	CbGeAlD
Haloperidol—Nausea—Donepezil—Alzheimer's disease	0.000104	0.000931	CcSEcCtD
Haloperidol—Dizziness—Rivastigmine—Alzheimer's disease	0.000103	0.00092	CcSEcCtD
Haloperidol—CYP2D6—cerebellum—Alzheimer's disease	0.000102	0.00215	CbGeAlD
Haloperidol—Vomiting—Memantine—Alzheimer's disease	0.000101	0.000905	CcSEcCtD
Haloperidol—Rash—Memantine—Alzheimer's disease	0.0001	0.000897	CcSEcCtD
Haloperidol—Dermatitis—Memantine—Alzheimer's disease	0.0001	0.000896	CcSEcCtD
Haloperidol—Headache—Memantine—Alzheimer's disease	9.97e-05	0.000891	CcSEcCtD
Haloperidol—Vomiting—Rivastigmine—Alzheimer's disease	9.9e-05	0.000885	CcSEcCtD
Haloperidol—Rash—Rivastigmine—Alzheimer's disease	9.81e-05	0.000877	CcSEcCtD
Haloperidol—Dermatitis—Rivastigmine—Alzheimer's disease	9.8e-05	0.000877	CcSEcCtD
Haloperidol—Headache—Rivastigmine—Alzheimer's disease	9.75e-05	0.000872	CcSEcCtD
Haloperidol—Nausea—Memantine—Alzheimer's disease	9.45e-05	0.000845	CcSEcCtD
Haloperidol—Nausea—Rivastigmine—Alzheimer's disease	9.24e-05	0.000827	CcSEcCtD
Haloperidol—HTR2A—brain—Alzheimer's disease	9.11e-05	0.00192	CbGeAlD
Haloperidol—CYP2D6—brain—Alzheimer's disease	8.3e-05	0.00175	CbGeAlD
Haloperidol—ABCB1—nervous system—Alzheimer's disease	7.81e-05	0.00164	CbGeAlD
Haloperidol—ABCB1—central nervous system—Alzheimer's disease	7.52e-05	0.00158	CbGeAlD
Haloperidol—ABCB1—cerebellum—Alzheimer's disease	7.35e-05	0.00155	CbGeAlD
Haloperidol—Loperamide—CYP2D6—Alzheimer's disease	7.34e-05	0.0248	CrCbGaD
Haloperidol—ABCB1—brain—Alzheimer's disease	5.97e-05	0.00126	CbGeAlD
Haloperidol—HRH1—Signaling Pathways—CCR5—Alzheimer's disease	2.44e-06	3.46e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.43e-06	3.45e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—HTR2A—Alzheimer's disease	2.43e-06	3.45e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.4e-06	3.41e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	2.39e-06	3.4e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ENO1—Alzheimer's disease	2.39e-06	3.39e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	2.39e-06	3.39e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—HTR2A—Alzheimer's disease	2.38e-06	3.39e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	2.38e-06	3.38e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NOS3—Alzheimer's disease	2.38e-06	3.37e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	2.37e-06	3.37e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	2.34e-06	3.32e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.34e-06	3.32e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—NOS3—Alzheimer's disease	2.3e-06	3.26e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CALM1—Alzheimer's disease	2.27e-06	3.22e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.26e-06	3.21e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—APOE—Alzheimer's disease	2.26e-06	3.21e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—LEP—Alzheimer's disease	2.26e-06	3.21e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—MTHFR—Alzheimer's disease	2.25e-06	3.19e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	2.24e-06	3.19e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NOS3—Alzheimer's disease	2.24e-06	3.18e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CAV1—Alzheimer's disease	2.24e-06	3.18e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	2.23e-06	3.17e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CALM1—Alzheimer's disease	2.23e-06	3.17e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CALM1—Alzheimer's disease	2.22e-06	3.16e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—CALM1—Alzheimer's disease	2.22e-06	3.16e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—APOE—Alzheimer's disease	2.22e-06	3.16e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—LEP—Alzheimer's disease	2.22e-06	3.16e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—BCHE—Alzheimer's disease	2.22e-06	3.15e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—APOE—Alzheimer's disease	2.22e-06	3.15e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—LEP—Alzheimer's disease	2.22e-06	3.15e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—APOE—Alzheimer's disease	2.22e-06	3.15e-05	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—AKT1—Alzheimer's disease	2.21e-06	3.14e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NOS3—Alzheimer's disease	2.21e-06	3.14e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	2.2e-06	3.13e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CAV1—Alzheimer's disease	2.2e-06	3.12e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—CAV1—Alzheimer's disease	2.19e-06	3.12e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CASP3—Alzheimer's disease	2.19e-06	3.11e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	2.19e-06	3.11e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—HMOX1—Alzheimer's disease	2.18e-06	3.1e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—IL6—Alzheimer's disease	2.18e-06	3.09e-05	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.17e-06	3.08e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	2.16e-06	3.06e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CASP3—Alzheimer's disease	2.15e-06	3.05e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—IL6—Alzheimer's disease	2.13e-06	3.03e-05	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—AKT1—Alzheimer's disease	2.13e-06	3.03e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—F2—Alzheimer's disease	2.13e-06	3.02e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	2.12e-06	3.01e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—ESR1—Alzheimer's disease	2.12e-06	3.01e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CASP3—Alzheimer's disease	2.11e-06	3e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—CALM1—Alzheimer's disease	2.1e-06	2.98e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	2.1e-06	2.98e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—IL6—Alzheimer's disease	2.1e-06	2.98e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—F2—Alzheimer's disease	2.1e-06	2.98e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	2.09e-06	2.97e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—APOE—Alzheimer's disease	2.09e-06	2.97e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—F2—Alzheimer's disease	2.09e-06	2.97e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	2.08e-06	2.96e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—CAV1—Alzheimer's disease	2.07e-06	2.95e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	2.06e-06	2.93e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	2.05e-06	2.92e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.05e-06	2.92e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.05e-06	2.91e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	2.05e-06	2.91e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.05e-06	2.91e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—LPL—Alzheimer's disease	2.04e-06	2.9e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	2.04e-06	2.89e-05	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.04e-06	2.89e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	2.03e-06	2.88e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CASP3—Alzheimer's disease	2.02e-06	2.86e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MAPK8—Alzheimer's disease	2.02e-06	2.86e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—AKT1—Alzheimer's disease	2.01e-06	2.85e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—IL6—Alzheimer's disease	2e-06	2.85e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—LPL—Alzheimer's disease	1.99e-06	2.83e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MAPK8—Alzheimer's disease	1.97e-06	2.8e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—AKT1—Alzheimer's disease	1.97e-06	2.8e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.97e-06	2.79e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	1.96e-06	2.78e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.94e-06	2.76e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MAPK8—Alzheimer's disease	1.94e-06	2.76e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	1.94e-06	2.75e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—AKT1—Alzheimer's disease	1.94e-06	2.75e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PPARG—Alzheimer's disease	1.93e-06	2.74e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—INS—Alzheimer's disease	1.93e-06	2.74e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	1.92e-06	2.73e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	1.92e-06	2.73e-05	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.92e-06	2.73e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	1.91e-06	2.71e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	1.9e-06	2.7e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CASP3—Alzheimer's disease	1.9e-06	2.7e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—INS—Alzheimer's disease	1.9e-06	2.7e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	1.9e-06	2.7e-05	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—AKT1—Alzheimer's disease	1.89e-06	2.69e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—INS—Alzheimer's disease	1.89e-06	2.69e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—INS—Alzheimer's disease	1.89e-06	2.69e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	1.89e-06	2.68e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—LPL—Alzheimer's disease	1.88e-06	2.67e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CASP3—Alzheimer's disease	1.88e-06	2.67e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	1.87e-06	2.65e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	1.87e-06	2.65e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—IL6—Alzheimer's disease	1.86e-06	2.65e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	1.86e-06	2.65e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—LPL—Alzheimer's disease	1.86e-06	2.65e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—VEGFA—Alzheimer's disease	1.86e-06	2.64e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MAPK8—Alzheimer's disease	1.85e-06	2.63e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—AKT1—Alzheimer's disease	1.85e-06	2.63e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.84e-06	2.62e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.84e-06	2.62e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	1.84e-06	2.61e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	1.84e-06	2.61e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	1.83e-06	2.6e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PPARG—Alzheimer's disease	1.82e-06	2.59e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.82e-06	2.59e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.81e-06	2.56e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.8e-06	2.55e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—VEGFA—Alzheimer's disease	1.79e-06	2.55e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—INS—Alzheimer's disease	1.79e-06	2.54e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.75e-06	2.48e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	1.75e-06	2.48e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	1.74e-06	2.48e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	1.74e-06	2.47e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MAPK8—Alzheimer's disease	1.73e-06	2.45e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—AKT1—Alzheimer's disease	1.72e-06	2.44e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CALM1—Alzheimer's disease	1.72e-06	2.44e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—APOE—Alzheimer's disease	1.71e-06	2.43e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.71e-06	2.43e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	1.71e-06	2.43e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.71e-06	2.43e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CAV1—Alzheimer's disease	1.7e-06	2.41e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	1.69e-06	2.4e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	1.69e-06	2.4e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.68e-06	2.38e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1.68e-06	2.38e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.67e-06	2.38e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—APOE—Alzheimer's disease	1.67e-06	2.37e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	1.66e-06	2.36e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	1.66e-06	2.36e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—NOS3—Alzheimer's disease	1.66e-06	2.36e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.66e-06	2.35e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TGFB1—Alzheimer's disease	1.65e-06	2.34e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.62e-06	2.29e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	1.61e-06	2.29e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—VEGFA—Alzheimer's disease	1.59e-06	2.26e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.59e-06	2.26e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.58e-06	2.25e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.58e-06	2.24e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.57e-06	2.23e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—NOS3—Alzheimer's disease	1.57e-06	2.23e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.57e-06	2.23e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.57e-06	2.22e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.56e-06	2.22e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.56e-06	2.22e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.55e-06	2.2e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	1.52e-06	2.16e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PPARG—Alzheimer's disease	1.49e-06	2.12e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	1.48e-06	2.1e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—INS—Alzheimer's disease	1.46e-06	2.08e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TGFB1—Alzheimer's disease	1.46e-06	2.08e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.46e-06	2.07e-05	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.45e-06	2.06e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.44e-06	2.04e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PTGS2—Alzheimer's disease	1.43e-06	2.04e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.43e-06	2.04e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—INS—Alzheimer's disease	1.43e-06	2.03e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.43e-06	2.03e-05	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.43e-06	2.03e-05	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.42e-06	2.02e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.41e-06	2.01e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	1.41e-06	2e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	1.41e-06	2e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.4e-06	1.99e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	1.4e-06	1.99e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	1.38e-06	1.96e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.37e-06	1.95e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.36e-06	1.93e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TP53—Alzheimer's disease	1.35e-06	1.92e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.35e-06	1.92e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—INS—Alzheimer's disease	1.35e-06	1.91e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.34e-06	1.91e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.34e-06	1.9e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.33e-06	1.9e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—INS—Alzheimer's disease	1.33e-06	1.89e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.32e-06	1.88e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.32e-06	1.87e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.32e-06	1.87e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.3e-06	1.84e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	1.3e-06	1.84e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.3e-06	1.84e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	1.29e-06	1.84e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	1.29e-06	1.84e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	1.29e-06	1.83e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—NOS3—Alzheimer's disease	1.28e-06	1.82e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	1.26e-06	1.79e-05	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—AKT1—Alzheimer's disease	1.25e-06	1.78e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.25e-06	1.78e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IL6—Alzheimer's disease	1.24e-06	1.76e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.23e-06	1.74e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TP53—Alzheimer's disease	1.22e-06	1.73e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.22e-06	1.73e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TP53—Alzheimer's disease	1.2e-06	1.71e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.2e-06	1.7e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.2e-06	1.7e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	1.19e-06	1.69e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	1.18e-06	1.68e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.18e-06	1.68e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.17e-06	1.67e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.17e-06	1.66e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	1.16e-06	1.65e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.16e-06	1.65e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.15e-06	1.63e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—AKT1—Alzheimer's disease	1.14e-06	1.62e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—INS—Alzheimer's disease	1.14e-06	1.62e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.12e-06	1.59e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IL6—Alzheimer's disease	1.12e-06	1.59e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.11e-06	1.57e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IL6—Alzheimer's disease	1.1e-06	1.56e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.1e-06	1.56e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.1e-06	1.56e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	1.09e-06	1.55e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.08e-06	1.53e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.07e-06	1.52e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—AKT1—Alzheimer's disease	1.06e-06	1.5e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.03e-06	1.47e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.03e-06	1.46e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.03e-06	1.46e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.02e-06	1.45e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—AKT1—Alzheimer's disease	1.02e-06	1.44e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1e-06	1.42e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TP53—Alzheimer's disease	9.21e-07	1.31e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	9.14e-07	1.3e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	9.06e-07	1.29e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TP53—Alzheimer's disease	9.04e-07	1.28e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PPARG—Alzheimer's disease	8.97e-07	1.27e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—INS—Alzheimer's disease	8.8e-07	1.25e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL6—Alzheimer's disease	8.43e-07	1.2e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	8.29e-07	1.18e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL6—Alzheimer's disease	8.28e-07	1.18e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	7.78e-07	1.1e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7.72e-07	1.1e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	7.65e-07	1.09e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	7.64e-07	1.08e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—AKT1—Alzheimer's disease	7.63e-07	1.08e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—AKT1—Alzheimer's disease	7.21e-07	1.02e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	7.06e-07	1e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—AKT1—Alzheimer's disease	5.9e-07	8.38e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—AKT1—Alzheimer's disease	5.76e-07	8.18e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—AKT1—Alzheimer's disease	5.43e-07	7.7e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—AKT1—Alzheimer's disease	5.38e-07	7.64e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—AKT1—Alzheimer's disease	4.6e-07	6.53e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.55e-07	5.04e-06	CbGpPWpGaD
